Navigation Links
Patient Recruitment Expert CSS Tapped to Host Master Workshop and Roundtable Discussions at Annual SCRS Site Solutions Summit Conference in October
Date:9/26/2013

GLEN BURNIE, Md., Sept. 26, 2013 /PRNewswire/ -- Clinical Site Services (CSS), the leader in global patient recruitment and enrollment solutions for the clinical research industry, is pleased to announce their participation in the annual Site Solutions Summit sponsored by the Society for Clinical Research Sites. 

Now in its 8th year, the Site Solutions Summit is an annual conference dedicated to helping clinical research sites reach optimal performance and achieve success. The Summit will be held October 11-13 in Amelia Island, Florida, and will host an array of workshops, roundtables, and networking opportunities focusing on "fresh strategies for remarkable performance" – the theme to this year's conference. As a Global Impact Partner of the SCRS, CSS will be hosting a Master Workshop, leading roundtable discussions as well as exhibiting information on their innovative approach to patient recruitment and enrollment solutions.

The CSS Master Workshop on October 11, titled, "Keeping up with the Changing Recruitment and Retention Environment," will be hosted by CSS President, Chris Trizna and Vice President, Jennifer Whitlock. For the third year, SCRS has asked CSS to lend their expertise in this area, as timely patient recruitment continues to be a challenge expressed by most investigative sites. The workshop will focus on how difficult protocols and competitive enrollment add up to potential difficulty in meeting patient recruitment and retention goals. Trizna explains, "We want to address how each site can arm themselves with the right plan of action, strategies and tactics to consistently enroll their studies."

"Our workshop is designed so that attendees will come away with solutions they can implement immediately," shared Trizna. "For example, helping them to understand the importance of the 'patient pathway' for each study and also the constantly evolving world of online media are two topics we will explore."

Ryan Haynes, Director of CSS's Site Management Solutions division, will also be hosting a roundtable discussion, titled, "Sizzle or Steak: What do Sponsors/CROs look for in sites?" This interactive round table will be co-led by representatives from an industry-leading CRO and a top executive from a pharmaceutical company. 

Haynes further explains, "Being involved with sponsor and CRO programs who rely on us for our patient recruitment solutions, CSS has a keen understanding of what these companies are seeking when they go into site selection. This roundtable will help sites learn best practices to make them a 'site of choice' in the eyes of sponsors and CROs."

Mr. Trizna has also been invited to be a panelist on the roundtable discussion, titled, "Managing Across Generations: Baby Boomers, Millennials, & Generation X and Y." Trizna shared, "Today's clinical trials must be approached with a specific attention to where and how potential participants can be reached. Each of these generations, or audiences, need to examined separately and thoroughly to determine the best course of action. They all have unique motivating factors, different media habits and challenges to participation."

The Site Solutions Summit began in 2006 in Santa Fe, New Mexico. Less than a dozen sites attended, but the idea of creating a place and voice for sites was much needed. Those same sites have been present at each Summit since, and attendance has nearly reached 600 and continues to grow each year – attracting both sites and sponsors/CROs, and providing sites the business intelligence that impacts their bottom line and future growth.  To learn more or to attend the 2013 Site Solutions Summit, visit www.SiteSolutionsSummit.com.

About CSS

Clinical Site Services (CSS) delivers global patient recruitment solutions that ensure successful enrollment, on time, every time. Through its innovative enrollment planning and full-service patient recruitment solutions, CSS is able to reduce the costs and timelines associated with recruitment of subjects for clinical studies. For more information on CSS, visit www.clinicalsiteservices.com, or contact Jennifer Whitlock at Email or 443-308-5803.

 

Contact:

Jennifer Whitlock

Clinical Site Services

P: 443-308-5803

F: 410-553-0087

Email

www.clinicalsiteservices.com

Read more news from Clinical Site Services.

 


'/>"/>
SOURCE Clinical Site Services
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Watching, Reading and Listening: A New Way to Interact with Patient Information
4. Phreesia identifies over 26% of patients who require additional autism evaluation
5. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
8. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
9. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
Breaking Medicine Technology:
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):